SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adline Chem Lab - Quaterly Results

23 May 2024 Evaluate
The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2024 is Rs. -0.35 millions as compared to Net Loss of Rs. -0.13 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -0.35% as compared to -0.13% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.27 0.75 -64.00 0.31 9.95 -96.88 0.31 9.95 -96.88
PBIDT -0.35 -0.13 169.23 -1.46 1.99 -173.37 -1.46 1.99 -173.37
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.35 -0.13 169.23 -1.46 -41.46 -96.48 -1.46 -41.46 -96.48
Depreciation 0.00 0.00 0.00 0.00 0.88 0.00 0.00 0.88 0.00
PBT -0.35 -0.13 169.23 -1.46 -42.34 -96.55 -1.46 -42.34 -96.55
TAX 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.35 -0.13 169.23 -1.47 -42.34 -96.53 -1.47 -42.34 -96.53
Equity 58.50 58.50 0.00 58.50 58.50 0.00 58.50 58.50 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Adline Chem Lab Share Price

11.28 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.75
Dr. Reddys Lab 1220.45
Cipla 1230.50
Zydus Lifesciences 930.70
Lupin 2313.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×